Rare diseases
Investigational molecules
Locations
Back to Germany46 clinical trials in Dessau-Roßlau, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
GermanyA Study of Darovasertib Before Surgery or Radiation Therapy for Patients with Early-Stage Uveal Melanoma That Has Not Spread
GermanyStudy on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy
GermanyAccelerating improvement with teclistamab plus standard drug combination in newly diagnosed transplant‑eligible multiple myeloma patients
GermanyStudy of inavolisib, ribociclib, and fulvestrant for patients with advanced hormone-receptor-positive, HER2-negative breast cancer.
GermanyA Study of Camizestrant and Ribociclib for Patients with Hormone Receptor-Positive Breast Cancer
GermanyA study testing zanidatamab combined with chemotherapy before surgery in patients with HER2-positive breast cancer
GermanyStudy of Trastuzumab Deruxtecan, Rilvegostomig, and Pembrolizumab for Advanced or Recurrent Endometrial Cancer in HER2-Positive Patients
GermanyStudy of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Advanced or Recurrent Endometrial Cancer
GermanyStudy on Pre-Operative Chemotherapy with Disodium Folinate, Oxaliplatin, and Fluorouracil for Patients with Advanced Resectable Colon Cancer
GermanyStudy on Elacestrant and Everolimus for Patients with Advanced ER+/HER2- Breast Cancer Resistant to Endocrine Therapy and CDK4/6 Inhibitors
GermanyStudy on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies focusing on breast cancer treatments, including trials for HER2-positive, hormone receptor-positive, and triple-negative variants. Research includes novel combination therapies and targeted treatments.
Notable investigations into pre-operative and post-resection treatments for various cancer types.
Innovative research addressing cardiovascular disease and cholesterol management, with trials evaluating new treatments for reducing cardiovascular events and managing lipid levels.
Focus on developing new therapeutic approaches for cardiovascular health improvement.
Clinical investigations of treatments for severe skin conditions, particularly focusing on hidradenitis suppurativa and other inflammatory skin disorders.
Evaluation of novel therapeutic agents for chronic skin conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
